OneMedNet Sets 1-for-10 Reverse Split to Regain Nasdaq Compliance
ONMD sits 27% above its 52-week low of $0.49.
Summary
OneMedNet will implement a 1-for-10 reverse stock split effective September 29, 2026, reducing outstanding shares from about 59.3 million to 5.9 million. The move aims to lift the stock above Nasdaq's $1 minimum bid requirement and broaden investor appeal. This follows the preliminary proxy filed August 7 seeking approval for a reverse split up to 1-for-20, and the company's recent $25 million equity line and $11.5 million data agreement. The split itself does not change market capitalization, but it addresses the delisting risk that has pressured the stock. Trading on a split-adjusted basis begins September 29 under the same ticker.
Updates
· SEC 8-K — The 8-K confirms the reverse split, reducing outstanding shares from about 60.13M to 6.01M as of Sept. 27, with new CUSIP 68270C 202.
At the time of this announcement, ONMD was trading at $0.62 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $36.8M. The 52-week trading range was $0.49 to $4.22. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.